JOEL A. TUMLISON MD NPI 1770658262

NPI Details

Joel A. Tumlison, MD is a family medicine in Tulsa, OK. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Joel A. Tumlison, MD NPI is 1770658262. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7600 S LEWIS AVE
TULSA, OK
ZIP 74136-836
Phone: (918) 493-7800
Fax: (918) 493-7888

The NPI 1770658262 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Coronavirus vaccine 14 (HCPCS:91313)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Coronavirus vaccine 13 (HCPCS:91312)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Administration of vaccine (HCPCS:90471)
• Administration of vaccine, each additional vaccine (HCPCS:90472)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)

The enumeration date for this NPI number is 11/21/2006 and was last updated on 7/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: